1. Home
  2. PCVX vs TFSL Comparison

PCVX vs TFSL Comparison

Compare PCVX & TFSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • TFSL
  • Stock Information
  • Founded
  • PCVX 2013
  • TFSL 1938
  • Country
  • PCVX United States
  • TFSL United States
  • Employees
  • PCVX N/A
  • TFSL N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • TFSL Savings Institutions
  • Sector
  • PCVX Health Care
  • TFSL Finance
  • Exchange
  • PCVX Nasdaq
  • TFSL Nasdaq
  • Market Cap
  • PCVX 6.0B
  • TFSL 3.9B
  • IPO Year
  • PCVX 2020
  • TFSL 2007
  • Fundamental
  • Price
  • PCVX $49.03
  • TFSL $13.69
  • Analyst Decision
  • PCVX Strong Buy
  • TFSL Hold
  • Analyst Count
  • PCVX 7
  • TFSL 1
  • Target Price
  • PCVX $101.67
  • TFSL $15.00
  • AVG Volume (30 Days)
  • PCVX 1.4M
  • TFSL 424.3K
  • Earning Date
  • PCVX 11-04-2025
  • TFSL 10-30-2025
  • Dividend Yield
  • PCVX N/A
  • TFSL 8.27%
  • EPS Growth
  • PCVX N/A
  • TFSL 14.29
  • EPS
  • PCVX N/A
  • TFSL 0.32
  • Revenue
  • PCVX N/A
  • TFSL $318,974,000.00
  • Revenue This Year
  • PCVX N/A
  • TFSL $10.29
  • Revenue Next Year
  • PCVX N/A
  • TFSL $3.28
  • P/E Ratio
  • PCVX N/A
  • TFSL $42.72
  • Revenue Growth
  • PCVX N/A
  • TFSL 4.70
  • 52 Week Low
  • PCVX $27.66
  • TFSL $11.29
  • 52 Week High
  • PCVX $98.17
  • TFSL $15.00
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 69.14
  • TFSL 53.28
  • Support Level
  • PCVX $40.14
  • TFSL $13.50
  • Resistance Level
  • PCVX $45.90
  • TFSL $14.03
  • Average True Range (ATR)
  • PCVX 2.30
  • TFSL 0.30
  • MACD
  • PCVX 0.26
  • TFSL 0.01
  • Stochastic Oscillator
  • PCVX 91.15
  • TFSL 59.06

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

Share on Social Networks: